Related Experiment Video
Updated: Jun 16, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Perioperative hyperglycemia: effect on outcome after infant congenital heart surgery
William M DeCampli1, Monica C Olsen, Hamish M Munro
1Congenital Heart Institute, Arnold Palmer Hospital for Children, Orlando, Florida 32806, USA. william.decampli@orlandohealth.com
Insights
Hyperglycemia (high blood sugar) after infant heart surgery does not increase mortality or infection risk. Other factors like age and surgical complexity predict longer recovery times.
Area of Science:
- Pediatric Cardiac Surgery
- Intensive Care Medicine
- Metabolic Disorders
Background:
- Cardiopulmonary bypass (CPB) is known to cause hyperglycemia (high blood glucose) during and after surgery.
- Hyperglycemia is a potential risk factor for adverse outcomes, including mortality, in infants undergoing cardiac surgery.
Purpose of the Study:
- To investigate the impact of glucose (GLU) levels during and after pediatric cardiac surgery on early postoperative outcomes.
- To determine if hyperglycemia is a significant predictor of morbidity and mortality in this patient population.
Main Methods:
- Retrospective review of 144 infants (<10 kg) undergoing CPB for congenital cardiac procedures.
- Analysis of glucose levels, age, weight, CPB duration, ultrafiltration, and RACHS-1 score.
- Univariate and multivariate regression models to assess predictors of mortality, infection, ventilation time, and length of stay.
Main Results:
- The Risk Adjustment for Congenital Heart Surgery (RACHS-1) score was the sole significant predictor of mortality or postoperative infection.
- Glucose levels at any time point were not significant predictors of mortality or infection.
- Lower pre-CPB glucose, younger age, and higher RACHS-1 scores predicted longer mechanical ventilation time and hospital length of stay.
Conclusions:
- Postoperative hyperglycemia was not identified as a risk factor for morbidity or mortality in infants following cardiac surgery.
- Surgical complexity (RACHS-1 score), patient age, and pre-operative glucose levels are more significant factors influencing recovery outcomes.
Background:
Studies demonstrate that cardiopulmonary bypass (CPB) causes intraoperative and postoperative hyperglycemia. Hyperglycemia has been associated with morbidity and mortality after infant cardiac surgery. We studied the effects on early postoperative outcomes of glucose (GLU) changes during and after pediatric cardiac surgery.
Methods:
The records of 144 infants less than 10 kg who underwent CPB for a variety of congenital cardiac procedures were reviewed. The GLU values (at multiple intervals during and after surgery), age, weight, CPB time, ultrafiltration volume, and risk adjustment for congenital heart surgery (RACHS-1) score were recorded. Univariate and multivariate linear and binary logistic regression were used to examine the dependence of the composite outcome mortality or postoperative infection, the mechanical ventilation time (VENT time), and the length of stay (LOS), on these variables.
Results:
The RACHS-1 score was the only significant predictor of the composite variable "mortality or infection" (p = 0.008). Glucose at any time was not a significant factor predicting this outcome. Lower pre-CPB GLU, younger age, and higher RACHS-1 score were significant predictors of greater LOS and VENT time.
Conclusions:
In this study, post-CPB and postoperative hyperglycemia were not risk factors for postoperative morbidity and mortality after infant cardiac surgery.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hyperglycemia
Complications of Diabetes Mellitus
Diabetes Mellitus: Type 2 and Gestational
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Hypoglycemia and Glucagon